Inhaled insulin fails to get FDA approval; 2 additional studies were requested. PDF Print
Bloomberg: MannKind Corp., the biotechnology company founded by billionaire inventor Alfred Mann, failed to win approval from U.S. regulators to market its first product, an inhaled insulin called Afrezza, for diabetes.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.